In Vitro Activities of the Novel Cephalosporin LB 11058 against Multidrug-Resistant Staphylococci and Streptococci

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 1, 2004, Pages 53-62

  Sader, Helio S ^a,b   Johnson, David M ^a   Jones, Ronald N ^a,c  

^a JMI LABORATORIES   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; LB 11058; UNCLASSIFIED DRUG;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CORYNEBACTERIUM; DRUG INHIBITION; DRUG POTENCY; DRUG SCREENING; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; INTERMETHOD COMPARISON; MICROBIAL SENSITIVITY TEST; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0346101456     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.1.53-62.2004     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin: United States. Morb. Mortal. Wkly. Rep. 51:565-567.
2. Chamberland, S., J. Blais, M. Hoang, C. Dinh, D. Cotter, E. Bond, C. Gannen, C. Park, F. Malouin, and M. N. Dudley. 2001. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria. Antimicrob. Agents Chemother. 45:1422-1430.
3. Cormican, M. G., and R. N. Jones. 1996. Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and non-pneumococcal streptococci. Drugs 51(Suppl. 1):6-12.
4. Diekema, D. J., and R. N. Jones. 2001. Oxazolidinone antibiotics. Lancet 358:1975-1982.
5. Diekema, D. J., M. A. Pfaller, F. J. Schmitz, J. Smayevsky, J. Bell, R. N. Jones, M. Beach, et al. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32(Suppl 2):S114-S132.
6. Dunne, M. W., C. Khurana, A. A. Mohs, A. Rodriguez, A. Arrieta, S. McLinn, J. A. Krogstad, M. Blatter, R. Schwartz, S. L. Vargas, P. Emparanza, P. Fernandez, W. M. Gooch III, M. Aspin, J. Podgore, I. Roine, J. L. Blumer, G. D. Ehrlich, and J. Chow. 2003. Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis. Antimicrob. Agents Chemother. 47:2663-2665.
7. Eliopoulos, G. M. 2003. Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin. Infect. Dis. 36:473-481.
8. Frank, A. L., J. F. Marcinak, P. D. Mangat, and P. C. Schreckenberger. 1999. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin. Infect. Dis. 29:935-936.
9. Fujimura, T., Y. Yamano, I. Yoshida, J. Shimada, and S. Kuwahara. 2003. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 47:923-931.
10. Hirano, L., and A. S. Bayer. 1991. β-Lactam-β -lactamase-inhibitor combinations are active in experimental endocarditis caused by β-lactamase-producing oxacillin-resistant staphylococci. Antimicrob. Agents Chemother. 35:685-690.
11. Jones, R. N. 2001. Resistance patterns among nosocomial pathogens. Trends over the past few years. Chest 119(2 Suppl.):397S-404S.
12. Jones, R. N., L. M. Deshpande, A. H. Mutnick, and D. J. Biedenbach. 2002. In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci. J. Antimicrob. Chemother. 50:915-932.
13. Jones, R. N., P. Della-Latta, L. V. Lee, and D. J. Biedenbach. 2002. Linezotid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 42:137-139.
14. Jones, T. F., M. E. Kellum, S. S. Porter, M. Bell, and W. Schaffner. 2002. An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg. Infect. Dis. 8:82-84.
15. Livermore, D. M. 2003. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36(Suppl. 1):S11-S23.
16. Lonks, J. R., J. Garau, L. Gomez, M. Xercavins, A. Ochoa de Echaguen, I. F. Gareen, P. T. Reiss, and A. A. Medeiros. 2002. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 35:556-564.
17. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 6th ed. Approved document M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing, 13th informational suppl., M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Paradisi, F., G. Corti, and R. Cinelli. 2001. Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains. Clin. Microbiol. Infect. 7(Suppl. 4):34-42.
20. Rowland, K. E., and J. D. Turnidge. 2000. The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children. Aust. N. Z. J. Med. 30:441-449.
21. Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, C. Lexau, A. Reingold, L. Lefkowitz, P. R. Cieslak, M. Cetron, E. R. Zell, J. H. Jorgensen, A. Schuchat, et al. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343:1917-1924.
22. Ziglam, H. M., and R. G. Finch. 2002. Penicillin-resistant pneumococci: implications for management of community-acquired pneumonia and meningitis. Int. J. Infect. Dis. 6(Suppl. 1):S14-S20.